PubMed

Dystrophia myotonia: why focus on foci?

Junghans RP.

Eur J Hum Genet. 2009 May;17(5):543-53. Epub 2009 Jan 28.PMID: 19172994 [PubMed - indexed for MEDLINE]Related articles

Second-generation anti-carcinoembryonic antigen designer T cells resist activation-induced cell death, proliferate on tumor contact, secrete cytokines, and exhibit superior antitumor activity in vivo: a preclinical evaluation.

Emtage PC, Lo AS, Gomes EM, Liu DL, Gonzalo-Daganzo RM, Junghans RP.

Clin Cancer Res. 2008 Dec 15;14(24):8112-22.PMID: 19088026 [PubMed - indexed for MEDLINE]Related articles

Sorting vector producer cells for high transgene expression increases retroviral titer.

Beaudoin EL, Bais AJ, Junghans RP.

J Virol Methods. 2008 Mar;148(1-2):253-9. Epub 2008 Feb 4.PMID: 18249448 [PubMed - indexed for MEDLINE]Related articles

Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML).

Yang W, Beaudoin EL, Lu L, Du Pasquier RA, Kuroda MJ, Willemsen RA, Koralnik IJ, Junghans RP.

Int Immunol. 2007 Sep;19(9):1083-93. Epub 2007 Jul 28.PMID: 17660502 [PubMed - indexed for MEDLINE]Related articlesFree article

Focused antibody response in plasma cell-infiltrated non-medullary (NOS) breast cancers.

Wang Y, Ylera F, Boston M, Kang SG, Kutok JL, Klein-Szanto AJ, Junghans RP.

Breast Cancer Res Treat. 2007 Aug;104(2):129-44. Epub 2007 Mar 28.PMID: 17393302 [PubMed - indexed for MEDLINE]Related articles

Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosing.

Koon HB, Severy P, Hagg DS, Butler K, Hill T, Jones AG, Waldmann TA, Junghans RP.

Leuk Res. 2006 Feb;30(2):190-203. Epub 2005 Sep 13.PMID: 16165209 [PubMed - indexed for MEDLINE]Related articles

Functional analysis of the mouse Fcgrt 5' proximal promoter.

Tiwari B, Junghans RP.

Biochim Biophys Acta. 2005 Jan 11;1681(2-3):88-98. Epub 2004 Nov 24.PMID: 15627500 [PubMed - indexed for MEDLINE]Related articles

Anti-prostate specific membrane antigen designer T cells for prostate cancer therapy.

Ma Q, Safar M, Holmes E, Wang Y, Boynton AL, Junghans RP.

Prostate. 2004 Sep 15;61(1):12-25.PMID: 15287090 [PubMed - indexed for MEDLINE]Related articles

Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.

Ma Q, DeMarte L, Wang Y, Stanners CP, Junghans RP.

Cancer Gene Ther. 2004 Apr;11(4):297-306.PMID: 15002034 [PubMed - indexed for MEDLINE]Related articles

RNA leaching of transcription factors disrupts transcription in myotonic dystrophy.

Ebralidze A, Wang Y, Petkova V, Ebralidse K, Junghans RP.

Science. 2004 Jan 16;303(5656):383-7. Epub 2003 Dec 4.PMID: 14657503 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetically engineered T cells as adoptive immunotherapy of cancer.

Ma Q, Gonzalo-Daganzo RM, Junghans RP.

Cancer Chemother Biol Response Modif. 2002;20:315-41. Review. No abstract available. PMID: 12703212 [PubMed - indexed for MEDLINE]Related articles

Generating potent Th1/Tc1 T cell adoptive immunotherapy doses using human IL-12: Harnessing the immunomodulatory potential of IL-12 without the in vivo-associated toxicity.

Emtage PC, Clarke D, Gonzalo-Daganzo R, Junghans RP.

J Immunother. 2003 Mar-Apr;26(2):97-106. Erratum in: J Immunother. 2003 May-Jun;26(3):290. Gonzalo-Dagonzo Rosa [corrected to Gonzalo-Daganzo Rosa]. PMID: 12616101 [PubMed - indexed for MEDLINE]Related articles

Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.

Coronella JA, Telleman P, Kingsbury GA, Truong TD, Hays S, Junghans RP.

Cancer Res. 2001 Nov 1;61(21):7889-99.PMID: 11691809 [PubMed - indexed for MEDLINE]Related articlesFree article

Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation.

Junghans RP, Ebralidze A, Tiwari B.

Neurogenetics. 2001 Mar;3(2):59-67. Review. No abstract available. PMID: 11354827 [PubMed - indexed for MEDLINE]Related articles

Biventricular cardiac thrombosis during interleukin-2 infusion.

Junghans RP, Manning W, Safar M, Quist W.

N Engl J Med. 2001 Mar 15;344(11):859-60. No abstract available. PMID: 11252319 [PubMed - indexed for MEDLINE]Related articles

Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors.

Yun CO, Nolan KF, Beecham EJ, Reisfeld RA, Junghans RP.

Neoplasia. 2000 Sep-Oct;2(5):449-59.PMID: 11191112 [PubMed - indexed for MEDLINE]Related articlesFree article

Coupling CD28 co-stimulation to immunoglobulin T-cell receptor molecules: the dynamics of T-cell proliferation and death.

Beecham EJ, Ma Q, Ripley R, Junghans RP.

J Immunother. 2000 Nov-Dec;23(6):631-42.PMID: 11186151 [PubMed - indexed for MEDLINE]Related articles

Direct immunoprecipitation of antigen with phage displaying immunoglobulin fragment.

Telleman P, Kingsbury GA, Junghans RP.

Biotechniques. 2000 Dec;29(6):1240-2, 1244, 1246 passim.PMID: 11126127 [PubMed - indexed for MEDLINE]Related articles

Anti-CD30 antibody-based therapy.

Koon HB, Junghans RP.

Curr Opin Oncol. 2000 Nov;12(6):588-93. Review.PMID: 11085459 [PubMed - indexed for MEDLINE]Related articles

Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells.

Coronella JA, Telleman P, Truong TD, Ylera F, Junghans RP.

Nucleic Acids Res. 2000 Oct 15;28(20):E85.PMID: 11024187 [PubMed - indexed for MEDLINE]Related articlesFree article

Interleukin 2 maintains biologic stability and sterility over prolonged time.

Safar M, Junghans RP.

Immunopharmacology. 2000 Sep;49(3):419-23.PMID: 10996039 [PubMed - indexed for MEDLINE]Related articles

Ultracentrifugal analysis of molecular mass of glycoproteins of unknown or ill-defined carbohydrate composition.

Lewis MS, Junghans RP.

Methods Enzymol. 2000;321:136-49. No abstract available. PMID: 10909055 [PubMed - indexed for MEDLINE]Related articles

The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bile.

Telleman P, Junghans RP.

Immunology. 2000 Jun;100(2):245-51.PMID: 10886402 [PubMed - indexed for MEDLINE]Related articlesFree article

Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor.

Beecham EJ, Ortiz-Pujols S, Junghans RP.

J Immunother. 2000 May-Jun;23(3):332-43.PMID: 10838662 [PubMed - indexed for MEDLINE]Related articles

Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.

Nolan KF, Yun CO, Akamatsu Y, Murphy JC, Leung SO, Beecham EJ, Junghans RP.

Clin Cancer Res. 1999 Dec;5(12):3928-41.PMID: 10632322 [PubMed - indexed for MEDLINE]Related articlesFree article

Cruel antibody fictions! Cellular antigen enumeration by 'saturation' binding.

Junghans RP.

Immunol Today. 1999 Sep;20(9):401-6. Review. No abstract available. PMID: 10532789 [PubMed - indexed for MEDLINE]Related articles

Anti-Gal antibodies-where's the beef?

Junghans RP.

Nat Biotechnol. 1999 Oct;17(10):938. No abstract available. Erratum in: Nat Biotechnol 1999 Dec;17(12):1146. PMID: 10504678 [PubMed - indexed for MEDLINE]Related articles

Measurement and biological correlates of antibody bioactivity during antibody immunotherapies.

Hagg DS, Junghans RP.

J Immunol Methods. 1998 Oct 1;219(1-2):7-21.PMID: 9831385 [PubMed - indexed for MEDLINE]Related articles

A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells.

Akamatsu Y, Murphy JC, Nolan KF, Thomas P, Kreitman RJ, Leung SO, Junghans RP.

Clin Cancer Res. 1998 Nov;4(11):2825-32.PMID: 9829749 [PubMed - indexed for MEDLINE]Related articlesFree article

Images in clinical medicine. Bone marrow involvement in acute leukemia.

Junghans RP.

N Engl J Med. 1998 Nov 5;339(19):1375. No abstract available. PMID: 9801399 [PubMed - indexed for MEDLINE]Related articles

Examination of a role for idiotypy in the disease remission of a long-term survivor of adult T cell leukemia treated with anti-Tac antibody.

Kingsbury GA, Waldmann TA, Junghans RP.

Leukemia. 1998 Jun;12(6):982-91.PMID: 9639430 [PubMed - indexed for MEDLINE]Related articles

Impact of antigenemia on the bioactivity of infused anti-Tac antibody: implications for dose selection in antibody immunotherapies.

Junghans RP, Carrasquillo JA, Waldmann TA.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1752-7.PMID: 9465089 [PubMed - indexed for MEDLINE]Related articlesFree article

IgG biosynthesis: no "immunoregulatory feedback".

Junghans RP.

Blood. 1997 Nov 15;90(10):3815-8. Review. No abstract available. PMID: 9354648 [PubMed - indexed for MEDLINE]Related articlesFree article

Next-generation Fc chimeric proteins: avoiding immune-system interactions.

Junghans RP.

Trends Biotechnol. 1997 May;15(5):155. No abstract available. PMID: 9161048 [PubMed - indexed for MEDLINE]Related articles

An optimized method for cell-based phage display panning.

Watters JM, Telleman P, Junghans RP.

Immunotechnology. 1997 Mar;3(1):21-9.PMID: 9154465 [PubMed - indexed for MEDLINE]Related articles

Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG.

Junghans RP.

Immunol Res. 1997 Feb;16(1):29-57. Review. Erratum in: Immunol Res 1997;16(2):215. PMID: 9048207 [PubMed - indexed for MEDLINE]Related articles

Optimization of radioligand binding and radioimmuno assays.

Junghans RP.

Anal Biochem. 1996 Aug 15;240(1):75-89. Erratum in: Anal Biochem 1997 Aug 15;251(1):133. PMID: 8811882 [PubMed - indexed for MEDLINE]Related articles

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor.

Junghans RP, Anderson CL.

Proc Natl Acad Sci U S A. 1996 May 28;93(11):5512-6.PMID: 8643606 [PubMed - indexed for MEDLINE]Related articlesFree article

Biophysical characterization of a recombinant soluble interleukin 2 receptor (Tac). Evidence for a monomeric structure.

Junghans RP, Stone AL, Lewis MS.

J Biol Chem. 1996 May 3;271(18):10453-60.PMID: 8631840 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.

Junghans RP, Waldmann TA.

J Exp Med. 1996 Apr 1;183(4):1587-602.PMID: 8666917 [PubMed - indexed for MEDLINE]Related articlesFree article

Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

Waldmann TA, White JD, Carrasquillo JA, Reynolds JC, Paik CH, Gansow OA, Brechbiel MW, Jaffe ES, Fleisher TA, Goldman CK, Top LE, Bamford R, Zaknoen E, Roessler E, Kasten-Sportes C, England R, Litou H, Johnson JA, Jackson-White T, Manns A, Hanchard B, Junghans RP, Nelson DL.

Blood. 1995 Dec 1;86(11):4063-75.PMID: 7492762 [PubMed - indexed for MEDLINE]Related articlesFree article

A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.

Chamow SM, Zhang D, Tan XY, Mhatre SM, Marsters SA, Peers DH, Byrn RA, Ashkenazi A, Junghans RP.

J Hematother. 1995 Oct;4(5):439-46.PMID: 8581382 [PubMed - indexed for MEDLINE]Related articles

Screening of phage display immunoglobulin libraries by anti-M13 ELISA and whole phage PCR.

Kingsbury GA, Junghans RP.

Nucleic Acids Res. 1995 Jul 11;23(13):2563-4. No abstract available. PMID: 7630737 [PubMed - indexed for MEDLINE]Related articlesFree article

A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.

Chamow SM, Zhang DZ, Tan XY, Mhatre SM, Marsters SA, Peers DH, Byrn RA, Ashkenazi A, Junghans RP.

J Immunol. 1994 Nov 1;153(9):4268-80.PMID: 7930627 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy.

Junghans RP, Dobbs D, Brechbiel MW, Mirzadeh S, Raubitschek AA, Gansow OA, Waldmann TA.

Cancer Res. 1993 Dec 1;53(23):5683-9.PMID: 8242624 [PubMed - indexed for MEDLINE]Related articlesFree article

An advanced solid support for immunoassays and other affinity applications.

Schmidt DE Jr, Brooks TL, Mhatre S, Junghans RP, Khazaeli MB.

Biotechniques. 1993 Jun;14(6):1020-5.PMID: 8333946 [PubMed - indexed for MEDLINE]Related articles

The multichain interleukin-2 receptor: a target for immunotherapy.

Waldmann TA, Pastan IH, Gansow OA, Junghans RP.

Ann Intern Med. 1992 Jan 15;116(2):148-60. Review.PMID: 1727619 [PubMed - indexed for MEDLINE]Related articles

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.

Brown PS Jr, Parenteau GL, Dirbas FM, Garsia RJ, Goldman CK, Bukowski MA, Junghans RP, Queen C, Hakimi J, Benjamin WR, et al.

Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2663-7.PMID: 2011577 [PubMed - indexed for MEDLINE]Related articlesFree article

Lymphokine receptor-directed therapy: a model of immune intervention.

Waldmann TA, Grant A, Tendler C, Greenberg S, Goldman C, Bamford R, Junghans RP, Nelson D.

J Clin Immunol. 1990 Nov;10(6 Suppl):19S-28S; discussion 28S-29S. Review.PMID: 2081786 [PubMed - indexed for MEDLINE]Related articles

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.

Junghans RP, Waldmann TA, Landolfi NF, Avdalovic NM, Schneider WP, Queen C.

Cancer Res. 1990 Mar 1;50(5):1495-502.PMID: 2406013 [PubMed - indexed for MEDLINE]Related articlesFree article